Structure-absorption relationships of a series of 6-fluoroquinolones

被引:41
作者
Escribano, E
Calpena, AC
Garrigues, TM
Freixas, J
Domenech, J
Moreno, J
机构
[1] UNIV VALENCIA,FAC FARM,DEPT FARM & TECNOL FARMACEUT,E-46100 BURJASSOT,SPAIN
[2] CENAVISA SA LABS,REUS,SPAIN
关键词
D O I
10.1128/AAC.41.9.1996
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The physicochemical constants and some structural parameters (topological, steric, and electronic) of eight third-generation monofluorate quinolones (six uncommercialized and two used clinically [ciprofloxacin and enrofloxacin]) were determined: pK(a), intrinsic solubility (S-O), chromatographic capacity factor, partition coefficient (P), valency molecular connectivity, molecular volume, molecular surface area, dipolar moment, and charges associated with each atom of the molecule. The apparent intestinal absorption rate constants (K-abs) in rat (in vivo perfusion) and the MICs at which 90% of the isolates are inhibited (MIC(90)s) against 100 Escherichia coli strains were also determined. We sought to establish simple nonlinear and multiple linear correlations between K-abs, on the one hand, and lipophilic parameters and other physicochemical and structural parameters estimated. Of the nonlinear functions examined, the hyperbolic had the best correlation between K-abs and P, which was in accordance with the Wagner-Sedman (J. G. Wagner and A. J. Sedman, J. Pharmacokinet. Biopharm. 1:23-50, 1973) equation, whereas, after application of the stepwise multiple linear regression method, a multiple linear correlation with some predictive value could be established only between K-abs as a dependent variable and log P and log S-O as independent variables. In conclusion, the K-abs and MIC90 of the quinolone CNV 8902 suggest that it is a sufficiently interesting compound to warrant the investigation of its potential therapeutic use orally.
引用
收藏
页码:1996 / 2000
页数:5
相关论文
共 22 条
[2]  
BARRE J, 1984, J PHARM SCI, V73, P1373
[3]  
CENAVISA SA, 1989, Patent No. 8901480
[4]  
COMPUDRUG, 1992, LABSWARE PROGRAM MAN
[5]   THE DEVELOPMENT AND USE OF QUANTUM-MECHANICAL MOLECULAR-MODELS .76. AM1 - A NEW GENERAL-PURPOSE QUANTUM-MECHANICAL MOLECULAR-MODEL [J].
DEWAR, MJS ;
ZOEBISCH, EG ;
HEALY, EF ;
STEWART, JJP .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1985, 107 (13) :3902-3909
[6]  
ESCRIBANO E, 1992, THESIS U BARCELONA B
[7]  
GERSTER JF, 1973, Patent No. 2264163
[8]   STRUCTURE-ACTIVITY-RELATIONSHIPS OF ANTI-BACTERIAL 6,7-DISUBSTITUTED AND 7,8-DISUBSTITUTED 1-ALKYL-1,4-DIHYDRO-4-OXOQUINOLINE-3-CARBOXYLIC ACIDS [J].
KOGA, H ;
ITOH, A ;
MURAYAMA, S ;
SUZUE, S ;
IRIKURA, T .
JOURNAL OF MEDICINAL CHEMISTRY, 1980, 23 (12) :1358-1363
[9]   THE PHARMACOKINETICS OF OFLOXACIN IN HEALTHY ADULT MALE-VOLUNTEERS [J].
LEROY, A ;
BORSA, F ;
HUMBERT, G ;
BERNADET, P ;
FILLASTRE, JP .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1987, 31 (05) :629-630
[10]   1,8-NAPHTHYRIDINE DERIVATIVES - A NEW CLASS OF CHEMOTHERAPEUTIC AGENTS [J].
LESHER, GY ;
GRUETT, MD ;
FROELICH, EJ ;
BRUNDAGE, RP ;
BAILEY, JH .
JOURNAL OF MEDICINAL & PHARMACEUTICAL CHEMISTRY, 1962, 5 (05) :1063-&